Reproducibility of Chronic and Acute Infarct Size Measurement by Delayed Enhancement-magnetic Resonance Imaging
Overview
Authors
Affiliations
Objectives: The aim of this study was to evaluate the reproducibility of acute and chronic infarct size (IS) by delayed enhancement (DE) magnetic resonance imaging (MRI).
Background: Infarct size measurements can be used as surrogate end point to reduce the sample size in studies comparing different reperfusion strategies in myocardial infarction (MI). Delayed enhancement MRI is a rather new technique, and so far infarct IS reproducibility has not been established appropriately.
Methods: In 21 patients (10 acute MI and 11 chronic MI), IS was assessed repeatedly on consecutive days by DE-MRI. Reproducibility, interobserver, and intraobserver variabilities were assessed and compared by the Bland-Altman method.
Results: Acute and chronic IS were 17.1 +/- 19.6% (range 5.1% to 69.8%) of LV mass (%LV) and 16.9 +/- 9.9 %LV (range 2.0% to 36.0%), respectively. Infarct size difference (bias) between scan I and scan II was -0.5 %LV, and limits of agreement were +/-2.4 %LV. Mean bias (-0.7 %LV) and limits of agreement (+/-3.2%) were slightly higher for acute in comparison with chronic MI with -0.4 +/- 1.3 %LV. Intraobserver and interobserver variability was low with a mean bias of 0.3 %LV (limits of agreement +/- 1.7 %LV) and -0.7 %LV (limits of agreement +/- 2.2 %LV), respectively.
Conclusions: Infarct size measurement by DE-MRI is an excellent tool for IS assessment, owing to its excellent repeatability in chronic and acute MI. It has therefore the potential to serve as a surrogate end point to uncover advantages of new reperfusion strategies.
Chen H, Erley J, Muellerleile K, Saering D, Jahnke C, Cavus E Eur Radiol. 2023; 34(3):1863-1874.
PMID: 37665392 PMC: 10873445. DOI: 10.1007/s00330-023-10100-9.
Xiao Z, Zhong J, Zhong L, Dai S, Lu W, Song L Eur Radiol. 2023; 33(11):8214-8225.
PMID: 37328640 DOI: 10.1007/s00330-023-09739-1.
Wang Q, Wang J, Ma Y, Wang P, Li Y, Tian J Front Pharmacol. 2022; 13:1015390.
PMID: 36313364 PMC: 9613930. DOI: 10.3389/fphar.2022.1015390.
Zhang Q, Burrage M, Shanmuganathan M, Gonzales R, Lukaschuk E, Thomas K Circulation. 2022; 146(20):1492-1503.
PMID: 36124774 PMC: 9662825. DOI: 10.1161/CIRCULATIONAHA.122.060137.
Role of cardiac magnetic resonance imaging in troponinemia syndromes.
Nguyen Nguyen N, Assad J, Femia G, Schuster A, Otton J, Nguyen T World J Cardiol. 2022; 14(4):190-205.
PMID: 35582465 PMC: 9048277. DOI: 10.4330/wjc.v14.i4.190.